
Medco and UnitedHealth announce details of their 2008 Medicare Part D prescription plans.

Medco and UnitedHealth announce details of their 2008 Medicare Part D prescription plans.

Walgreens launches catalogue, Web site for AARP members

FDA makes changes to levothyroxine potency specifications

Erbitux approved as single agent for metastatic colorectal cancer

CMS has issued clarification for mass immunizers and centralized billers.

FFF Enterprises launches MyFluVaccine provider network

Hypermune products now latex-free

DEA proposes self-certification fee for sellers of scheduled listed chemical products

URAC names first companies to earn PBM accreditations

SmartCare offers flu immunizations

A black box warning for nephrogenic systemic fibrosis has been added to the prescribing information of gadolinium-based contrast agents.

Beginning in January, CMS will require NPI numbers for Medicare.

Medicare Part D plans raised drug prices during plan year, according to a study by Consumer Reports.

Medical board survey shows increased prosecution of overprescribers and need for addiction education

Public support exists for access to experimental drugs

FDA approves Verigene test for warfarin (Coumadin) metabolism

Drug mix-ups occur frequently in Pennsylvania

Lamisil oral granules are approved by the FDA for tinea capitis

Docetaxel approved for squamous cell head and neck cancer

Another influenza vaccine approved for seasonal flu

FDA advisory committee to discuss OTC cough/ cold products in children under six

Rite Aid celebrates American Pharmacists Month with contest

Take Care Health Systems to expand with Walgreens

AstraZeneca to offer free medicines for healthcare facilities

NACDS thanks Senate for pharmacy provision for military families.

Bartell, Novartis launch FluGram prepaid influenza vaccination card.

The Fair Medicaid Drug Payment Act of 2007 would fix the average manufacturers price rule and promote generic drugs.

A bipartisan group of lawmakers has formed the Congressional Community Pharmacy Coalition to advocate on pharmacy issues.

FDA proposes chlorofluorocarbon (CFC) removal from epinephrine inhalers.